
Scientists profile FDA-approved drugs to potentially treat hundreds of genetic disorders
New method developed by UC Riverside researchers quickly assesses drug potential for rare disorders

Researchers develop molecular traps to target SARS-CoV-2
Joint effort by UC Riverside and UCLA scientists aims to stop the COVID-19-spreading virus from attacking immune cells

Scientists discover new avian immunological pathway
UC Riverside-led team identifies a new host protein interaction that produces a robust immune response to viral infection in birds and may lead to better poultry vaccines

Is it time to wear a highly efficient medical grade facemask?
UC Riverside experts weigh in

A more targeted therapy to treat inflammatory bowel disease
UC Riverside mouse study focuses on the receptor TNFR1

New hope for people living with a genetic cause of autism
UC Riverside research shows gene reactivation can be used to treat Fragile X syndrome

O my, here’s Omicron
UC Riverside experts share their thoughts on the new COVID-19 variant

Study links high cholesterol, cardiovascular disease to plastics
UC Riverside-led mouse study finds a receptor greatly contributes to the harmful effects of plastic-associated chemicals

Deafness trumps HIV for deaf people living with HIV
UC Riverside-led study participants advocate for collection of more data on deaf individuals

New model links cultural trauma with health inequalities
UC Riverside researchers offer new interpretation of cultural trauma

How sepsis need not be fatal
UC Riverside-led team identifies molecular driver and protector of this life-threatening medical emergency

Public lecture to focus on synthetic genome engineering
Lei Stanley Qi of Stanford University will give the 2021 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside

Why is it taking so long to approve a COVID-19 vaccine for kids?
UC Riverside vaccine expert David Lo explains